Cue Biopharma

Business Services · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

40 Guest St, Boston, Massachusetts, 0213...

Phone Number

(617) 949-2680

Revenue

$37.7 Million

Stock Symbol

CUE

Industry

Business Services Manufacturing Pharmaceuticals Research & Development

About Cue Biopharma

Cue Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutic biologics designed to selectively engage and modulate disease-relevant immune cells. The company is dedicated to advancing treatments for immunological disorders, including allergic and autoimmune diseases, with the goal of enabling functional cures and improving patient outcomes. Its research and development efforts are centered on leveraging the body's natural immune mechanisms through precision-targeted therapies that address underlying disease processes while minimizing the risks associated with broad immune system modulation.Explore more
Cue Biopharma's Social MediaSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: CUEShow more

Cue Biopharma Org Chart

LW
United States flag for contact location.

Interim President & Chief Executive Officer

PhoneEmail
Ron Oyston, Chief Administrative Officer at Cue Biopharma
United States flag for contact location.

Chief Administrative Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
DB
United States flag for contact location.

Interim Chief Development Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Cue Biopharma

Compare insights from companies similar to Cue Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Cue Biopharma

$37.7M
11-50
Public
$176.2M
2014
LW
Lucinda WarrenInterim President & CEO
$22.4M
11-50
Public
$6.8M
2003
$15.6M
11-50
Public
$576.7M
2015
Michael Listgarten, General Counsel at ALX Oncology
Michael ListgartenGeneral Counsel
<$5M
11-50
Private
$33.3M
2010
DG
David GearingChief Scientific Officer
<$5M
1-10
Public
<$5M
2011
JP
James ParslowChief Financial Officer
<$5M
1-10
Private
$52M
2007
David Block, Gliknik Co-Founder and Chief Executive Officer at Gliknik
David BlockGliknik Co-Founder and CEO
1-10
Public
$19.4M
2013
Sumit Aggarwal, President & Chief Executive Officer at Eloxx Pharmaceuticals
Sumit AggarwalPresident & CEO
Illustration of an envelope

Cue Biopharma Tech Stack

A closer look at the technologies used by Cue Biopharma

Top Business Services Companies

Frequently Asked Questions Regarding Cue Biopharma

What is Cue Biopharma's stock symbol?
Cue Biopharma's stock symbol is CUE
What is Cue Biopharma's official website?
Cue Biopharma's official website is www.cuebiopharma.com
What is Cue Biopharma's Revenue?
Cue Biopharma's revenue is $37.7 Million
What is Cue Biopharma's SIC code?
Cue Biopharma's SIC: 87,873
What is Cue Biopharma's NAICS code?
Cue Biopharma's NAICS: 54,541
How many employees does Cue Biopharma have?
Cue Biopharma has 11-50 employees
What industry does Cue Biopharma belong to?
Cue Biopharma is in the industry of: Business Services, Manufacturing, Pharmaceuticals
What is Cue Biopharma competition?
Cue Biopharma top competitors include: Gliknik, Nexvet Biopharma, Aridis Pharmaceuticals, Xenetic Biosciences
What technology does Cue Biopharma use?
Some of the popular technologies that Cue Biopharma uses are: WordPress.org, PHP, Cloudflare Website Optimization, Google Universal Analytics
How do I contact Cue Biopharma?
Cue Biopharma contact info: Phone number: (617) 949-2680 Website: www.cuebiopharma.com
What does Cue Biopharma do?

Cue Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutic biologics designed to selectively engage and modulate disease-relevant immune cells. The company is dedicated to advancing treatments for immunological disorders, including allergic and autoimmune diseases, with the goal of... enabling functional cures and improving patient outcomes. Its research and development efforts are centered on leveraging the body's natural immune mechanisms through precision-targeted therapies that address underlying disease processes while minimizing the risks associated with broad immune system modulation.Read More

What are Cue Biopharma social media links?
Cue Biopharma Linkedin page Cue Biopharma Twitter page
Who invested in Cue Biopharma?
Cue Biopharma has 5 investors including Public Ventures Corportation and Piper Sandler.
Is Cue Biopharma a public company?
Yes, Cue Biopharma is a public company and is traded under the symbol CUE
See more information about Cue Biopharma

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.